Video
Physicians Might Under Dose ACEs and ARBs Due to Acute Kidney Injury
Chi Chu, MD, an assistant professor in the division of nephrology at the University of California San Francisco, why providers might under dose ACE and ARB treatments for proteinuria.
In a Pharmacy Times® interview, Chi Chu, MD, an assistant professor in the division of nephrology at the University of California San Francisco, spoke about his 2021 ASN Kidney Week presentation on the submaximal dose of angiotensin converting enzyme (ACE) inhibitor and angiotensin II receptor blockers (ARB) for individuals with proteinuria.
He discussed why providers might under dose ACE and ARB treatments for proteinuria.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
